CHCHD1 and ovarian cancer: GO pathway analyses showed that the translational initiation pathway (GO:0006413) was the most significant pathway involved with FAU,RBM4,POLR2G,NLRP3,TLR1,TLR6,TLR2,MRPL33, MRPS16, MRPL12,MRPL11,MRPL21,CHCHD1,TLR2 and MRPS16 have been reported to be associated with the development of ovarian cancer in previous studies [34].